Athos Capital Ltd Purchases New Shares in Kenvue Inc. $KVUE

Key Points

• Athos Capital acquired 682,724 Kenvue shares worth approximately $13.0 million, making KVUE its seventh-largest portfolio holding at 4.6%. Institutional investors collectively own 97.64% of the stock.
• Kenvue reported quarterly revenue of $3.96 billion and EPS of $0.31, slightly below analyst expectations, though revenue increased 3% year over year. Analysts expect full-year EPS of $1.14.
• The company pays a quarterly dividend of $0.21 per share, equivalent to an annualized yield of about 4.4%. Analysts maintain a consensus “Hold” rating with an average price target of $19.27, close to the stock’s $19.08 price.

Athos Capital Ltd purchased a new position in Kenvue Inc. (NYSE:KVUE - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 682,724 shares of the company's stock, valued at approximately $13,047,000. Kenvue makes up 4.6% of Athos Capital Ltd's investment portfolio, making the stock its 7th biggest position.

A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Kenvue by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 234,951,484 shares of the company's stock worth $4,052,913,000 after buying an additional 1,604,040 shares during the period. BlackRock Inc. acquired a new position in Kenvue in the 2nd quarter worth approximately $2,882,279,000. State Street Corp boosted its stake in Kenvue by 3.5% in the 4th quarter. State Street Corp now owns 118,865,134 shares of the company's stock worth $2,050,424,000 after purchasing an additional 4,063,257 shares during the period. Geode Capital Management LLC boosted its stake in Kenvue by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company's stock worth $856,778,000 after purchasing an additional 371,322 shares during the period. Finally, Independent Franchise Partners LLP grew its position in Kenvue by 56.3% during the 4th quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company's stock worth $830,527,000 after purchasing an additional 17,343,785 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Up 0.1%

KVUE opened at $19.08 on Monday. The company has a market capitalization of $36.65 billion, a PE ratio of 21.93, a price-to-earnings-growth ratio of 1.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $21.78. The business has a 50-day moving average of $19.05 and a 200-day moving average of $18.20.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). The business had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. Kenvue's revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.29 EPS. Equities research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 4.4%. This is an increase from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, August 12th. Kenvue's dividend payout ratio is 96.55%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on KVUE. Weiss Ratings upgraded Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, June 15th. Wall Street Zen downgraded Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. UBS Group dropped their price target on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 11th. Barclays increased their price objective on Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 21st. Finally, Zacks Research lowered Kenvue from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 7th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $19.27.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source